Published in J Am Coll Cardiol on March 20, 2007
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol (2009) 2.49
Prenatal exposure to cigarette smoke induces diet- and sex-dependent dyslipidemia and weight gain in adult murine offspring. Environ Health Perspect (2009) 1.57
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circ Cardiovasc Qual Outcomes (2011) 1.47
Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause (2016) 1.41
Women's health in menopause with a focus on hypertension. Neth Heart J (2009) 1.15
Development of a PubMed Based Search Tool for Identifying Sex and Gender Specific Health Literature. J Womens Health (Larchmt) (2015) 1.15
Coronary heart disease in women: a challenge for the 21st century. Clinics (Sao Paulo) (2010) 1.14
Cardiac syndrome X and microvascular coronary dysfunction. Trends Cardiovasc Med (2012) 1.12
The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab (2007) 1.09
Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study. J Gen Intern Med (2008) 1.04
Nutritional aspects of phytoene and phytofluene, carotenoid precursors to lycopene. Adv Nutr (2011) 1.01
A multisite examination of sex differences in cardiac rehabilitation barriers by participation status. J Womens Health (Larchmt) (2009) 1.01
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. PLoS One (2013) 0.88
Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review. Indian J Endocrinol Metab (2012) 0.87
Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection? J Lipids (2012) 0.85
One more look at guidelines for primary and secondary prevention of cardiovascular disease in women. Arch Med Sci (2011) 0.83
Preventable hospitalizations and emergency department visits for angina, United States, 1995-2010. Prev Chronic Dis (2013) 0.82
National trends in visits to physician offices and outpatient clinics for angina 1995 to 2010. Circ Cardiovasc Qual Outcomes (2014) 0.82
Depression and coronary heart disease. ISRN Cardiol (2012) 0.82
Low high-density lipoprotein cholesterol: current status and future strategies for management. Vasc Health Risk Manag (2010) 0.82
Age and sex mediated changes in epicardial fat adipokines. Atherosclerosis (2010) 0.81
Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial. Am J Obstet Gynecol (2010) 0.81
Myocardial contractility is preserved early but reduced late after ovariectomy in young female rats. Reprod Biol Endocrinol (2011) 0.80
The relationships between FAM5C SNP (rs10920501) variability and metabolic syndrome and inflammation in women with coronary heart disease. Biol Res Nurs (2011) 0.79
Imaging Tests, Provocative Tests, Including Exercise Testing in Women with Suspected Coronary Artery Disease. Curr Cardiovasc Risk Rep (2012) 0.78
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists. Biol Sex Differ (2016) 0.78
The change in motivating factors influencing commencement, adherence and retention to a supervised resistance training programme in previously sedentary post-menopausal women: a prospective cohort study. BMC Public Health (2015) 0.77
Gender differences in myocardial perfusion defect in asymptomatic postmenopausal women and men with and without diabetes mellitus. J Womens Health (Larchmt) (2013) 0.77
Blood cholesterol trends 2001-2011 in the United States: analysis of 105 million patient records. PLoS One (2013) 0.77
Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons. Curr Cardiovasc Risk Rep (2010) 0.77
Noninvasive assessment of coronary artery disease in women: What's next? Curr Cardiol Rep (2010) 0.76
Progression and observational frequency of atheromatous plaques in autopsied coronary arteries. Korean Circ J (2009) 0.75
Proposal of quality indicators for cardiac rehabilitation after acute coronary syndrome in Japan: a modified Delphi method and practice test. BMJ Open (2017) 0.75
Cardiac rehabilitation with a nurse case manager (GoHeart) across local and regional health authorities improves risk factors, self-care and psychosocial outcomes. A one-year follow-up study. JRSM Cardiovasc Dis (2014) 0.75
Coronary artery bypass graft surgery and primary percutaneous coronary intervention choices in patients with similar coronary anatomy: A computer-based simulation examines the sex gap. Can J Cardiol (2009) 0.75
Effects of Hormone Therapy on Serum Lipid Levels in Postmenopausal Korean Women. J Menopausal Med (2015) 0.75
Cardiovascular disease in women--challenges deserving a comprehensive translational approach. J Cardiovasc Transl Res (2009) 0.75
Overt and Covert Anxiety as a Toxic Factor in Ischemic Heart Disease in Women: The Link Between Psychological Factors and Heart Disease. Med Sci Monit (2017) 0.75
Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis (2016) 0.75
Trends of Prevalence of Uncontrolled Risk Factors for Cerebrocardiovascular Disease: Southern Italy from 1988/9 to 2008/9. Cholesterol (2016) 0.75
Stable ischemic heart disease in women: current perspectives. Int J Womens Health (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Standards of medical care in diabetes--2014. Diabetes Care (2014) 20.97
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med (2007) 18.78
Standards of medical care in diabetes--2008. Diabetes Care (2008) 17.23
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med (2005) 15.18
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Standards of medical care in diabetes--2007. Diabetes Care (2007) 12.35
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2005) 11.91
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
Universal definition of myocardial infarction. Circulation (2007) 11.69
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med (2008) 9.50
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (2006) 9.40
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Diagnosis and classification of diabetes mellitus. Diabetes Care (2011) 9.37
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34
Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 9.16
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
Economic costs of diabetes in the US in 2002. Diabetes Care (2003) 8.92
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med (2006) 8.74
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70